By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Meridian Bioscience today reported a 32 percent jump in second quarter revenues, aided by "strong" results from its molecular diagnostic test for C. difficile and its recently acquired Bioline business.

For the three months ended March 31, Meridian posted $41.1 million in revenues, up from $31.1 million a year ago, but slightly short of consensus Wall Street expectations of $41.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: biobank of colorectal cancer organoids, ancient wolf genome analysis, and more.

With cloud computing becoming more attractive to researchers, Nature News offers some tips on how to get going.

In a series of articles, medical journals debate the necessity of conflict-of-interest policies.

Irwin Rose, who won the 2004 Nobel Prize in Chemistry for his work on ubiquitin-mediated protein degradation, has died.